Cargando…
Safety profile of the antiviral drug remdesivir: An update
Autores principales: | Fan, Qianqian, Zhang, Bo, Ma, Jie, Zhang, Shuyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Masson SAS.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373689/ https://www.ncbi.nlm.nih.gov/pubmed/32707440 http://dx.doi.org/10.1016/j.biopha.2020.110532 |
Ejemplares similares
-
Greek Remdesivir Cohort (GREC) Study: Effectiveness of Antiviral Drug Remdesivir in Hospitalized Patients with COVID-19 Pneumonia
por: Petrakis, Vasilis, et al.
Publicado: (2022) -
Safety, Tolerability, and Pharmacokinetics of Remdesivir, An Antiviral for Treatment of COVID‐19, in Healthy Subjects
por: Humeniuk, Rita, et al.
Publicado: (2020) -
A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir
por: Liang, Chengyuan, et al.
Publicado: (2020) -
Off-Target In Vitro Profiling Demonstrates that Remdesivir Is a Highly Selective Antiviral Agent
por: Xu, Yili, et al.
Publicado: (2021) -
An Updated Systematic Review on Remdesivir’s Safety and Efficacy in Patients Afflicted With COVID-19
por: Yasir, Mohamed, et al.
Publicado: (2023)